cawd-176,欧美 性爱 国产 综合,亚洲国产黄色在线,庆余年在线观看免费
中文簡(jiǎn)體
中文簡(jiǎn)體
English
HOME
ABOUT US
Company Profile
Company Culture
Company Honor
R&D
Technology Platform
Pipelines
NEWS
Press Release
Awards
CAREERS
CONTACT US
中文簡(jiǎn)體
中文簡(jiǎn)體
English
Search
Committed to Pioneering Innovation in Drug Development
ABOUT US
Putting Patients First, Innovation for All
Pursuing Excellence, Unwavering Persistence
R&D
Championing Patient Well-being,
Ensuring a Healthy Future
CAREERS
innovation
R&D
Precision Delivery Technology Platform
Beihai Biotech, with a global footprint and ambitious aspirations, has developed a Proprietary Precision Delivery Technology Platform.
Learn More
PDC Technology Platform
Beihai Biotech has developed a cutting-edge platform of Peptide-Drug Conjugate (PDC).
Learn More
A Robust Pipeline of 8 Promising Innovative Drug Candidates
Diverse Therapeutic Areas: Breast cancer, non-small cell lung cancer, prostate cancer, stomach cancer...
Learn More
Technology Platform
Pipelines
NEWS
NEWS
Beihai Biotech announced that its innovative cancer drug, BH009 (marketed as BEIZRAY), has received approval from the U.S. Food and Drug Administration (FDA)
Learn More
U.S. FDA Formally Accepts Beihai Biotech's New Drug Application for Innovative Oncology Drug BH009 (BEIZRAY?)
Learn More
Beihai Biotech Founder Dr. Sun Invited to Keynote 'Wisdom in China' Summit at Renmin University Business School
Learn More
Beihai Biotech Successfully Concludes Series C Funding, Expediting BH009 Commercialization and Advancing Clinical Trials for Innovative Drug Candidates
Learn More
See More
ABOUT US
R&D
NEWS
CAREERS
CONTACT US
Contact Information
Company address：Blg 2, No. 6366, Zhuhai Ave., Jinwan, Zhuhai, 519090, China
Tel：0756-6349669
Human resources contact：hr@bayhibiotech.com
Business cooperation contact：hjiang@bayhibiotech.com
Wechat Official Account
Copyright ? 2023 Zhuhai Beihai Biotech Co., Ltd.
Copyright Registration No. :
Guangdong ICP for 17134092
Technical support :
Xiangxun Technology
